EGFR Mutated Non-small Cell Lung Cancer Patients Clinical Trial
Official title:
Observational Retrospective Study to Describe the Management of Advanced or Metastatic EGFR (Epidermal Growth Factor Receptor) Mutated Non-small Cell Lung Cancer Patients in Spain
This is a national, multicentre, non-interventional, retrospective study to be carried out
in the oncology settings of approximately 15-20 Spanish hospitals.
At each participant hospital, all patients recently diagnosed with advanced EGFR mutated
NSCLC (both newly or with recurrent disease , without previous treatment for metastatic
disease) from April 2010 to December 2011 will be included as study population. Information
about the follow-up of the patients during a minimum of 12 months after diagnosis will be
collected.
Observational retrospective study to describe the management of advanced or metastatic EGFR mutated non-small cell lung cancer patients in Spain ;
Time Perspective: Retrospective